Tag: Clinical Research
-
Peer-Reviewed Studies Validate Linus Health AI as an Early Digital Biomarker for Alzheimer’s Pathology
Groundbreaking Findings Show AI Detects Alzheimer’s Pathology Earlier New peer-reviewed studies confirm that Linus Health’s artificial intelligence (AI) platform can indicate Alzheimer’s disease pathology before noticeable symptoms emerge. The research suggests that this early digital biomarker could empower patients, caregivers, and healthcare teams to take timely actions that may slow disease progression and preserve independence.…
-
Early Digital Biomarker: Linus Health AI Signals Alzheimer’s Pathology Before Symptoms
Groundbreaking Validation: Linus Health AI as an Early Digital Biomarker New peer‑reviewed studies validate Linus Health AI as a cutting-edge digital biomarker for Alzheimer’s pathology. The research suggests that the AI can indicate the presence of Alzheimer’s-related changes in the brain before noticeable cognitive symptoms arise, offering a window of opportunity for proactive intervention. By…
-
Sparsentan Delivers Positive Phase 3 Results in Japanese IgA Nephropathy
Overview: sparsentan earns positive topline data in Japanese IgA nephropathy Renalys Pharmaceutical Co. announced encouraging topline results from a Phase 3 study evaluating sparsentan, a dual-acting agent, in Japanese patients with IgA nephropathy (IgAN). The trial focused on the safety and efficacy of sparsentan in a specific, well-defined cohort (N=35) and sought to determine whether…
-
Shorter Hormone Therapy May Suffice for Prostate Cancer
New findings suggest shorter hormone therapy could be enough for many men with prostate cancer For years, androgen deprivation therapy (ADT) has been a mainstay in treating prostate cancer, often prescribed for extended periods to slow tumor growth. But a new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center points to…
-
Drugs Without Nausea: Scientists Target Brain Circuits to Separate Side Effects from Weight-Loss Benefits
Overview: Aiming for Nausea-Free Weight-Loss Drugs Nausea has long been a common hurdle for people using weight-loss medications such as Ozempic and other GLP-1 receptor agonists. While these drugs can help curb appetite and promote weight loss, the unpleasant side effect of nausea can limit adherence and diminish quality of life. In response, scientists are…
-
Drugs Without Nausea: Scientists Target Brain to Separate Side Effects
Overview: Aiming to keep the appetite, not the nausea Nausea is a common hurdle for millions using modern weight-loss medications, from GLP-1 receptor agonists to newer formulations. As scientists race to expand the benefits of these drugs, a central question guides the research: can the brain’s pathways be fine-tuned so that the appetite-suppressing effects remain,…
-
Victoria launches world-leading cancer detection technology for earlier diagnosis
Victoria unveils world-leading cancer detection technology Patients across Victoria are set to benefit from a landmark advance in cancer care as a new, world-leading scanning technology becomes available through the state’s health system. The installation marks a major milestone in diagnosis, treatment planning, and ongoing research, with clinicians emphasising that the scanner will enable earlier…
-
New M102 Drug Could Substantially Slow Motor Neurone Disease Progression, Scientists Say
Overview: A potential breakthrough in motor neurone disease research In a development that could reshape the outlook for people living with motor neurone disease (MND), scientists report that a novel drug, M102, has shown promise in substantially slowing the disease’s progression. While still in the preclinical stage, the findings suggest that M102 works by safeguarding…
-
Long COVID researchers uncover link between microclots and NETs, shedding light on lingering symptoms
New study spotlights a possible physiological link in long COVID Scientists are delving deeper into the mystery of long COVID, and a recent study adds a crucial piece to the puzzle. Researchers have identified a structural association between circulating microclots and neutrophil extracellular traps (NETs) in patients experiencing prolonged symptoms after COVID-19. While not a…
-
New Clues in the Long COVID Puzzle: Microclots and NETs Linked
Unraveling a Complex Puzzle Scientists have taken another meaningful step in understanding long COVID, uncovering a structural link between circulating microclots and neutrophil extracellular traps (NETs). This discovery adds to a growing body of evidence that the syndrome may involve a subtle interplay between the immune system and the blood’s clotting machinery. While the findings…